Is implementation of the 5 a's of smoking cessation at community mental health centers effective for reduction of smoking by patients with serious mental illness?

American Journal on Addictions

Volumn 18, Issue 5, 2009, Pages 386-392

  Dixon, Lisa B ^a,b   Medoff, Deborah ^a,b   Goldberg, Richard ^a,b   Lucksted, Alicia ^a,b   Kreyenbuhl, Julie ^a,b   Diclemente, Carlo ^c   Potts, Wendy ^a   Leith, Jaclyn ^a   Brown, Clayton ^a,b   Adams, Curtis ^a   Afful, Joseph ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; CLOZAPINE; OLANZAPINE; QUETIAPINE; RISPERIDONE; ZIPRASIDONE;

ADULT; AFFECTIVE PSYCHOSIS; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COMMUNITY MENTAL HEALTH CENTER; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; PATIENT COUNSELING; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; SCHIZOPHRENIA; SMOKING CESSATION;

ADULT; COMMUNITY MENTAL HEALTH CENTERS; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HUMANS; MALE; MENTAL DISORDERS; PATIENT COMPLIANCE; PROFESSIONAL PRACTICE; SMOKING; SMOKING CESSATION; TIME FACTORS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 71049123279     PISSN: 10550496     EISSN: 15210391     Source Type: Journal    
DOI: 10.1080/10550490903077747     Document Type: Article

References (34)

1. U.S. Department of Health and Human Services. The health effects of active smoking: A report of the Surgeon General. Washington, DC: U.S. Government Printing Office; 2004
2. Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung cancer risk. JAMA. 2005;294:1505-1510
3. De Leon J, Diaz FJ. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr Res. 2005;76:135-157
4. Lasser K, Boyd JW, Woolhander S, Himmelstein D, McCormick D, Bor DH. Smoking and mental illness: A population-based prevalence study. JAMA. 2000;284:2606-2610
5. Waxmonsky JA, Thomas MR, Miklowitz DJ, et al. Prevalence and correlates of tobacco use in bipolar disorder: Data from the first 2000 participants in the systematic treatment enhancement program. Gen Hosp Psychiatry. 2005;27:321-328
6. Fagerstrom K, Aubin HJ. Management of smoking cessation in patients with psychiatric disorders. Curr Med Res Opin. 2009;25:511-518
7. Ziedonis D, Hitsman B, Beckham JC, et al. Tobacco use and cessation in psychiatric disorders: National Institute of Mental Health report. Nicotine Tob Res. 2008;10:1691-1715
8. George TP, Vessicchio JC, Sacco KA, et al. A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia. Biol Psychiatry. 2008;63:1092-1096
9. Baker A, Richmond R, Haile M, et al. A randomized controlled trial of a smoking cessation intervention among people with a psychotic disorder. Am J Psychiatry. 2006;163:1934-1942
10. Thorndike AN, Stafford RS, Rigotti NA. US physicians' treatment of smoking in outpatients with psychiatric diagnoses. Nicotine Tob Res. 2001;3:85-91
11. Lucksted A, Dixon LB, Sembly JB. A focus group pilot study of tobacco smoking among psychosocial rehabilitation clients. Psychiatr Serv. 2000;51:1544-1548
12. Carosella AM, Ossip-Klein DJ, Owens CA. Smoking attitudes, beliefs, and readiness to change among acute and long term care inpatients with psychiatric diagnoses. Addict Behav. 1999;24:331-344
13. Drake RE, Mercer-McFadden C, Mueser KT, McHugo GJ, Bond GR. Review of integrated mental health and substance abuse treatment for patients with dual disorders. Schizophr Bull. 1998;24:589-608
14. Hellerstein DJ, Rosenthal RN, Miner CR. Integrating services for schizophrenia and substance abuse. Psychiatr Q. 2001;72:291-306
15. Fiore MC, Bailey WC, Cohen SJ, et al. Treating tobacco use and dependence: Clinicalpractice guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2000
16. Fiore MC, Jaen CR, Baker TB, et al. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service; 2008
17. Dixon L, Medoff D, Wohlheiter K, et al. Correlates of smoking severity among persons with serious mental illness. Am J Addict. 2007;16:101-110
18. US Department of Health and Human Services,National Center for Health Statistics. Third U.S. National Health and Nutrition Examination Survey (NHANES III), 1988-1994 Hyattsville, Md: Dept of Health and Human Services; 1996
19. Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom test for nicotine dependence: A revision of the Fagerstrom tolerance questionnaire. Br J Addict. 1991;86:1119-1127
20. Bedfont Scientific U. EC50 Microl III Smokerlyzer Breath Carbon Monoxide Monitor. Medford, New Jersey, USA
21. Jarvis MJ, Russell MA, Saloojee Y. Expired air carbon monoxide: A simple breath test of tobacco smoke intake. BMJ. 1980;281: 484-485
22. Ewing JA. Detecting alcoholism: The CAGE questionnaire. JAMA. 1984;252:1905-1907
23. Mayfield D, McLeod G, Hall P. The CAGE questionnaire: Validation of a new alcoholism screening instrument. Am J Psychiatry. 1974;10:1121-1123
24. Hays RD,Merz JF, Nicholas R. Response burden, reliability, and validity of the CAGE, short MAST, and AUDIT alcohol screening measures. Behav Res Methods Instrum Comput. 1995;27:277-280
25. Perkins D, Stroup TS, Lieberman JA. Assessment of psychotic disorders. In: Rush AJ, Pincus HA, First MB, et al., eds. American Psychiatric Association Handbook of psychiatric measures,Washington, DC: American Psychiatric Association Press, 2000:485-513
26. Cohen S, Kamarack T, Mermelstein R. A global measure of perceived stress. J Health Soc Behav. 1983;24:385-396
27. Scacapan S, Oskamp S, Cohen S, Wlliamson G. Perceived stress in a probability sample of the United States. In: Anonymous, ed. The social psychology of health. Newbury Park, CA: Sage; 1988: 31-67
28. Fitzmaurice GM, Laird NM,Ware JH. Applied longitudinal analysis. New York: Wiley; 2004
29. Health Services/Technology Assessment Text AHRQ Technical Reviews and Summaries, AHCPR Supported Clinical Practice Guidelines, Quick Reference Guide, Consumer Guides (English), Consumer Guides (Spanish), AIDSInfo, AHCPR Supported Clinical Practice Guidelines
30. Treating Tobacco Use and Dependence: 2008 Update, Tables, Table 6.5. Available at (http://www.ncbi.nlm.nih.gov/books/bv.fcg?ridhstat2. table.29539) Accessed on February 8, 2009
31. Health Services/Technology Assessment Text AHRQ Technical Reviews and Summaries, AHCPR Supported Clinical Practice Guidelines, Quick Reference Guide, Consumer Guides (English), Consumer Guides (Spanish), AIDSInfo, AHCPR Supported Clinical Practice Guidelines
32. Treating Tobacco Use and Dependence: 2008 Update, Tables, Table 6.7. Available at (http://www.ncbi.nlm.nih.gov/books/bv.fcg?ridhstat2. table.295341) Accessed on February 8, 2009
33. McEvoy J, Freudenreich O, McGee M, VanderZwaag C, Levin E, Rose J. Clozapine decreases smoking in patients with chronic schizophrenia. Biol Psychiatry. 1995;37:550-552
34. George TP, Ziedonis DM, Feingold A, et al. Nicotine transdermal patch and atypical antipsychotic medications for smoking cessation in schizophrenia. Am J Psychiatry. 2000;157:1835-1842